FDA Inspection
Abbvie Biotechnology Ltd.Abbvie Biotechnology Ltd. – FDA Inspection, Oct 30, 2023
Record Details
This FDA Inspection record concerns Abbvie Biotechnology Ltd., with an inspection on October 30, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · fbc58704-0c5e-4f2c-8caa-a8e38cd2ba1a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1222107
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Abbvie Biotechnology Ltd.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2026 | Not classified | San Juan District Office | Drug Quality Assurance |
| March 25, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 13, 2017 | Not classified | San Juan District Office |
Other documents for Abbvie Biotechnology Ltd.
- FDA Inspection 1321476 - 2026-06-10
- FDA Inspection 1084057 - 2019-03-25
- FDA Inspection 1055102 - 2018-06-01
- FDA Inspection 1012249 - 2017-04-28
- FDA Inspection 1001477 - 2017-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.